Siedlecki Łukasz, Szyguła-Jurkiewicz Bożena, Pyka Łukasz, Król Bogumiła, Szczurek Wioletta, Gąsior Mariusz
3 Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland.
3 Department of Cardiology, Silesian Centre for Heart Diseases, Zabrze, Poland.
Kardiochir Torakochirurgia Pol. 2017 Sep;14(3):170-174. doi: 10.5114/kitp.2017.70530. Epub 2017 Sep 30.
Diabetes mellitus (DM) and heart failure (HF) are two common diseases that often co-exist.
To explore clinical characteristics, management strategies and rates of 3-year mortality among diabetic and non-diabetic patients hospitalised in a highly specialized interventional cardiology centre.
We used data from COMMIT-HF (COnteMporary Modalities In Treatment of Heart Failure), which is a single-centre, observational, prospective registry of patients with symptomatic chronic systolic HF (LVEF < 35%). Data collected included demographics, clinical characteristics, medical history, inpatient therapies and procedures. Follow-up was based on the information acquired from the national health-care provider.
We analysed 1397 patients out of the total of 1798 patients included in the COMMIT-HF registry between 2009 and 2013. We identified 595 (42.6%) diabetic and 802 (57.4%) non-diabetic patients. Compared to patients without DM, patients with type 2 DM had a higher rate of comorbidity. Frequency of death in patients with DM during the 3-year follow-up was significantly higher than in patients without DM (199 (33.4%) vs. 163 (20.3%), < 0.0001, respectively).
In the analysed HF population representing patients receiving typical, everyday clinical care, the prevalence of DM is 42.6%. Diabetes mellitus has deleterious effects on renal function and symptoms as assessed by the New York Heart Association functional class. DM remains associated with increased frequency of death in patients with HF, in spite of recent pharmacological and device-based advances in HF management.
糖尿病(DM)和心力衰竭(HF)是两种常并存的常见疾病。
探讨在一家高度专业化的介入心脏病中心住院的糖尿病患者和非糖尿病患者的临床特征、管理策略及3年死亡率。
我们使用了来自COMMIT-HF(心力衰竭当代治疗模式)的数据,这是一项针对有症状的慢性收缩性心力衰竭(左心室射血分数<35%)患者的单中心、观察性、前瞻性登记研究。收集的数据包括人口统计学、临床特征、病史、住院治疗及操作。随访基于从国家医疗保健机构获取的信息。
我们分析了2009年至2013年COMMIT-HF登记研究中纳入的1798例患者中的1397例。我们识别出595例(42.6%)糖尿病患者和802例(57.4%)非糖尿病患者。与无糖尿病的患者相比,2型糖尿病患者的合并症发生率更高。糖尿病患者在3年随访期间的死亡频率显著高于无糖尿病的患者(分别为199例(33.4%)对163例(20.3%),<0.0001)。
在所分析的代表接受日常典型临床护理患者的心力衰竭人群中,糖尿病患病率为42.6%。糖尿病对肾功能和纽约心脏协会功能分级评估的症状有有害影响。尽管近期在心力衰竭管理方面有基于药物和器械的进展,但糖尿病仍然与心力衰竭患者的死亡频率增加相关。